顯示具有 G6PD缺乏症避免使用的藥物 標籤的文章。 顯示所有文章
顯示具有 G6PD缺乏症避免使用的藥物 標籤的文章。 顯示所有文章

2016年4月23日 星期六

G6PD缺乏症避免使用的藥物

MIMS Summary TableMIMS Summary Table


DRUGS TO AVOID IN G6PD DEFICIENCY
DEFINITE RISK OF HAEMOLYSISDEFINITE RISK OF HAEMOLYSIS POSSIBLE RISK OF HAEMOLYSISPOSSIBLE RISK OF HAEMOLYSIS
Pharmacological ClassPharmacological Class Drugs*Drugs* Pharmacological ClassPharmacological Class Drugs*Drugs*
AnthelminticsAnthelmintics • ß-Naphthol
• Niridazole
• Stibophen• ß-Naphthol
• Niridazole
• Stibophen
AnalgesicsAnalgesics • Acetylsalicylic acid (Aspirin)
• Acetanilide
• Paracetamol (Acetaminophen)
• Aminophenazone (Aminopyrine)
• Dipyrone (Metamizole)
• Phenacetin
• Phenazone (Antipyrine)
• Phenylbutazone
• Tiaprofenic acid• Acetylsalicylic acid (Aspirin)
• Acetanilide
• Paracetamol (Acetaminophen)
• Aminophenazone (Aminopyrine)
• Dipyrone (Metamizole)
• Phenacetin
• Phenazone (Antipyrine)
• Phenylbutazone
• Tiaprofenic acid
AntibioticsAntibiotics • Nitrofurans
- Nitrofurantoin
- Nitrofurazone
• Quinolones
- Ciprofloxacin
- Moxifloxacin
- Nalidixic acid
- Norfloxacin
- Ofloxacin
• Chloramphenicol
• Sulfonamides
- Co-trimoxazole (Sulfamethoxazole + Trimethoprim)
- Sulfacetamide
- Sulfadiazine
- Sulfadimidine
- Sulfamethoxazole
- Sulfanilamide
- Sulfapyridine
- Sulfasalazine (Salazosulfapyridine)
- Sulfisoxazole (Sulfafurazole)• Nitrofurans
- Nitrofurantoin
- Nitrofurazone
• Quinolones
- Ciprofloxacin
- Moxifloxacin
- Nalidixic acid
- Norfloxacin
- Ofloxacin
• Chloramphenicol
• Sulfonamides
- Co-trimoxazole (Sulfamethoxazole + Trimethoprim)
- Sulfacetamide
- Sulfadiazine
- Sulfadimidine
- Sulfamethoxazole
- Sulfanilamide
- Sulfapyridine
- Sulfasalazine (Salazosulfapyridine)
- Sulfisoxazole (Sulfafurazole)
AntibioticsAntibiotics • Furazolidone
• Streptomycin
• Sulfonamides
- Sulfacytine
- Sulfaguanidine
- Sulfamerazine
- Sulfamethoxypyridazole• Furazolidone
• Streptomycin
• Sulfonamides
- Sulfacytine
- Sulfaguanidine
- Sulfamerazine
- Sulfamethoxypyridazole
AnticonvulsantsAnticonvulsants • Phenytoin• Phenytoin
AntidiabeticsAntidiabetics • Glibenclamide• Glibenclamide
AntidotesAntidotes • Dimercaprol (BAL)• Dimercaprol (BAL)
AntihistaminesAntihistamines • Antazoline (Antistine)
• Diphenhydramine
• Tripelennamine• Antazoline (Antistine)
• Diphenhydramine
• Tripelennamine
AntimalarialsAntimalarials • Mepacrine
• Pamaquine
• Pentaquine
• Primaquine• Mepacrine
• Pamaquine
• Pentaquine
• Primaquine
AntihypertensivesAntihypertensives • Hydralazine
• Methyldopa• Hydralazine
• Methyldopa
Antimethemo- globinaemic AgentsAntimethemo- globinaemic Agents • Methylene blue• Methylene blue AntimalarialsAntimalarials • Chloroquine & derivatives
• Proguanil
• Pyrimethamine
• Quinidine
• Quinine• Chloroquine & derivatives
• Proguanil
• Pyrimethamine
• Quinidine
• Quinine
AntimycobacterialsAntimycobacterials • Dapsone
• Para-aminosalicylic acid
• Sulfones
- Aldesulfone sodium (Sulfoxone)
- Glucosulfone
- Thiazosulfone• Dapsone
• Para-aminosalicylic acid
• Sulfones
- Aldesulfone sodium (Sulfoxone)
- Glucosulfone
- Thiazosulfone
Antimycobacterials • Isoniazid
Antiparkinsonism Agents • Trihexyphenidyl (Benzhexol)
Antineoplastic Adjuncts • Doxorubicin
• Rasburicase
Cardiovascular Drugs • Dopamine (L-dopa)
• Procainamide
• Quinidine
Genitourinary Analgesics • Phenazopyridine (Pyridium) Diagnostic Agent
for Cancer Detection
• Toluidine blue
Others • Acetylphenylhydrazine
• Phenylhydrazine
Gout Preparations • Colchicine
• Probenecid


Hormonal Contraceptives • Mestranol
Nitrates • Isobutyl nitrite
Vitamin K Substance • Menadiol Na sulfate
• Menadione
• Menadione Na bisulfite
• Phytomenadione
Vitamins • Ascorbic acid (Vit C) (rare)
Others • Arsine
• Berberine
(in Coptis chinensis)
• Fava beans
• Naphthalene (in mothballs)
• Para-aminobenzoic acid
*Nomenclature based on INN (International non-proprietary name)


Refer to www.g6pd.org for further information.


Please refer to the Contents page for more Summary Tables.


Copyright © 2006 MIMS


ver01032006











資料來源:財團法人嘉義基督教醫院
http://www.cych.org.tw/pharm/searchdrug.aspx



以上資料只作參考之用,詳情請諮詢醫生











2014年2月27日 星期四

香港蘋果日報:止嘔藥Domperidona 兩歲以下不宜服用

香港蘋果日報
A12 | 港聞 | 2015-02-27
止嘔藥Domperidona 兩歲以下不宜服用
【專家之言】
對於澳門五個月大患有蠶豆症男嬰猝死,醫生被指開錯藥,有香港藥劑師指涉事的兩種藥物,其中一種止嘔藥不建議供兩歲以下嬰孩服用,在外國更有警告指長者服用可致死亡;但有心臟科醫生稱兩種藥物均不是蠶豆症禁服藥物。
加國︰長者服用可致命
香港醫院藥劑師學會會長崔俊明指,止嘔藥Domperidona可治療腸胃不適及作嘔作悶。今年一月,加拿大衞生當局發出警告,指六十歲以上長者服用此藥,可引致心律不齊、心臟停頓及突然死亡等風險。而本港醫生使用此止嘔藥,一般建議兩歲以上小孩才可服用。但崔表示,醫生有權為兩歲以下嬰孩處方此藥作「非適應症治療」,但必須同時向病童父母表明風險。
心臟科醫生何鴻光稱,蠶豆症病人一旦服錯藥致病發,會出現溶血症致貧血,會致全身黃疸、小便轉色等病徵,即使有致命風險,亦非半日內會發生,「多幾日先會有事」。對於蠶豆症,醫學界有一禁用藥物列表,但涉事兩種藥物均非列表內,其中止嘔藥更屬常用藥物,會按醫生臨床判斷是否處方予病童。
■記者龔蕙芝








資料來源:G6PD 缺乏症/蠶豆症資訊站
https://www.facebook.com/G6PD-%E7%BC%BA%E4%B9%8F%E7%97%87%E8%A0%B6%E8%B1%86%E7%97%87%E8%B3%87%E8%A8%8A%E7%AB%99-215564885253417/?fref=ts
以上資料只作參考之用,詳情請諮詢醫生